Search

Your search keyword '"Grzelakowski, P."' showing total 34 results

Search Constraints

Start Over You searched for: Author "Grzelakowski, P." Remove constraint Author: "Grzelakowski, P."
34 results on '"Grzelakowski, P."'

Search Results

1. Number of triple points on complete intersection Calabi-Yau threefolds

2. Some estimations of the {\L}ojasiewicz exponent

3. Type III contractions and quintic threefolds

4. Rapid fabrication of precise high-throughput filters from membrane protein nanosheets

10. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients

12. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

13. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

14. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy

15. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial

16. Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

17. Extended thromboprophylaxis with betrixaban in acutely ill medical patients

18. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

19. Apixaban for extended treatment of venous thromboembolism

21. Amphiphilic Copolymer Membranes Promote NADH:Ubiquinone Oxidoreductase Activity: Towards an ElectronTransfer Nanodevice

22. Inhibition of Macrophage Phagocytotic Activity by a Receptor-targeted Polymer Vesicle-based Drug Delivery Formulation of Pravastatin

27. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

28. Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: A subanalysis of the COV-HF-SIRIO 6 study.

29. Longer Hospitalizations and Higher In-Hospital Mortality for Acute Heart Failure during the COVID-19 Pandemic in Larger vs. Smaller Cardiology Departments: Subanalysis of the COV-HF-SIRIO 6 Multicenter Study.

30. Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).

31. A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.

32. The effects of percutaneous transluminal coronary intervention on biomarkers of oxidative stress in the erythrocytes of elderly male patients.

33. [Acute intermediate-risk pulmonary embolism with right-sided free-floating intracardiac thrombus, systemic inflammatory reaction syndrome, multiple organ dysfunction syndrome, disseminated intravascular coagulation and acute ischaemia of a limb].

Catalog

Books, media, physical & digital resources